7.27
Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie
Is Cullinan Therapeutics Inc. stock poised for growthFree Fundamental Winners With Safe Entry Plan - Newser
Is Cullinan Therapeutics Inc. showing signs of accumulationMonthly Long-Term Market Recap and Summary - Newser
Full technical analysis of Cullinan Therapeutics Inc. stockFree Swing Trade With Risk Management - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathProven Trading System with Consistent Gains - Newser
Market reaction to Cullinan Therapeutics Inc.’s recent newsTechnical Trade Plan with Entry Checklist - Newser
Is Cullinan Therapeutics Inc. stock reversal real or fakeEntry and Exit Strategy for Swing Traders - Newser
How Cullinan Therapeutics Inc. stock performs during market volatilityFree Community Shared Smart Money Signals - Newser
William Blair Has Pessimistic Outlook of CGEM Q3 Earnings - Defense World
Can swing trading help recover from Cullinan Therapeutics Inc. lossesEquity Performance Forecast Based on AI Models - Newser
Key resistance and support levels for Cullinan Therapeutics Inc.Free Value Investing Picks With Stability - Newser
Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionSector-Wise Stock Strength Trend Analysis - Newser
Cullinan (CGEM) Q2 R&D Jumps 68% - AOL.com
How to track smart money flows in Cullinan Therapeutics Inc.Stock Market Trend and Pattern Analysis - Newser
Using Ichimoku Cloud for Cullinan Therapeutics Inc. technicalsDay Trading Setup and Momentum Analysis - Newser
Cullinan Therapeutics: Q2 Earnings Snapshot - Greenwich Time
Cullinan Therapeutics Reports Q2 2025 Financial Results - TipRanks
What to expect from Cullinan Therapeutics Inc. in the next 30 daysPrice Movement and Market Sentiment Analysis - Newser
Cullinan Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cullinan Therapeutics reports Q2 EPS ($1.07), consensus (86c) - TipRanks
Cullinan Therapeutics Reports Wider-Than-Expected Q2 LossNews and Statistics - IndexBox
Cullinan Therapeutics (CGEM) to Release Earnings on Thursday - Defense World
Cullinan Management Appoints New Board Members - TipRanks
Cullinan Therapeutics Q2 net loss widens to $70.1 mln on higher R&D costs - MarketScreener
Cullinan Therapeutics, Inc. SEC 10-Q Report - TradingView
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - The Manila Times
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire Inc.
Real time social sentiment graph for Cullinan Therapeutics Inc.Swing Trade Timing with Daily Forecast - Newser
How to manage a losing position in Cullinan Therapeutics Inc.Breakout Monitoring with Momentum Analysis - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):